Riskpilot← Back to searchSign inGet full accessCymbathera AB
ABActiveOrg 5594225699Scheeletorget 1Manufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 20231-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
-666% vs 2023
Equity ratio
89.6%
Financial strength
Net profit 2024
SEK -636K
-681% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -681K | -666% |
| Net profit | SEK -636K | -681% |
| Total assets | SEK 5,8M | +1255% |
| Equity | SEK 5,2M | +1339% |
| Employees | — | — |
Legal name
Cymbathera AB
Org number
5594225699
Legal form
Aktiebolag
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
16 februari 2023
Share capital
SEK 499 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla, tillverka och kommersialisera medicinteknisk utrustning samt därmed förenlig verksamhet.
Address
Scheeletorget 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 200 | 0 |
| Staff expenses | — | — |
| EBITDA | −89 | −681 |
| Depreciation & amort. | — | −0 |
| EBIT | −89 | −681 |
| Net financials | 7 | 45 |
| Profit before tax | −81 | −636 |
| Tax | — | −0 |
| Net profit | −81 | −636 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 431 | 5 835 |
| Equity | 364 | 5 231 |
| Long-term debt | — | 0 |
| Short-term debt | 67 | 604 |
| Total debt | 67 | 604 |
EBITDA margin
-68100000.0%
This company
15.8%
Market median
-431012758% vs market
20232024
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20232024
Return on equity
-12.2%
This company
18.4%
Market median
-166% vs market
20232024
Net profit margin
-63600000.0%
This company
8.1%
Market median
-785185285% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BG Chief Executive Officer | Chief Executive Officer | 2026 |
AK Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
KA Chief Auditor | Chief Auditor | 2023 – 2024 |
TJ Chief Auditor | Chief Auditor | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cymbathera AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Anders Brofors Ekblom | Chief Auditor | 0 companies |
| Bengt Göran Brorsson | Chief Executive Officer | 0 companies |
| Teddy Joakim Hampus Liljesson | Chief Auditor | 0 companies |
| Anna Karolina Widecrantz | Chief Auditor | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Jonathan Hiram Kagan | Board of Directors | 0 companies |
| Ulf Gunnar Andersson | Board of Directors | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Jan Peter Andersson | Board of Directors | 0 companies |
| Anette Maria Sjögren | Board of Directors | 0 companies |